On May 26, Beijing Zonci Technology Development Co., Ltd. welcomed a distinguished delegation of more than ten European medical industry experts, distributors, and business partners. This visit marked not only a cross-border exchange of ideas and cooperation, but also a valuable opportunity for in-depth discussions on advancements in the field of coagulation diagnostics.

Zonci Excellence, Shaping the Future Through Innovation

As a leading Chinese manufacturer in the coagulation diagnostics industry, Zonci has consistently driven growth through independent innovation, focusing on the research, development, and commercialization of advanced coagulation testing technologies. During the visit, the delegation toured the company's R&D center, intelligent manufacturing facilities, and quality control laboratories. They gained comprehensive insights into Zonci's integrated production system, spanning from component development and precision manufacturing to final instrument assembly and quality assurance.

The delegation was introduced to Zonci’s comprehensive portfolio of self-developed coagulation analyzers, showcasing the company’s strong commitment to innovation and technological excellence. Among the highlights was the SPACE Series Full Automatic Coagulation Analyzer, renowned as a flagship standalone coagulation solution. The series has earned numerous prestigious recognitions, including the German Red Dot Design Award, Innovative Medical Device Certification, an “Internationally Advanced” Scientific and Technological Achievement Evaluation, and the Tsinghua University New Quality Design Award. The delegation also explored the XL120 Series Coagulation Analyzer, designed for single-sample, multi-parameter testing with a compact footprint and exceptional flexibility for diverse laboratory settings, as well as the XL3690 Series Full Automatic Coagulation Analyzer, a high-performance platform engineered to meet a wide range of clinical testing requirements.

Building upon these innovative products, Zonci has developed a comprehensive thrombosis and hemostasis testing solution, covering the full spectrum of clinical workflows and application scenarios. Through an integrated ecosystem that combines advanced instrumentation, intelligent diagnostic platforms, and professional service support, Zonci enables efficient, accurate, and reliable coagulation testing, providing laboratories with a solid foundation for high-quality clinical decision-making and patient care.

Strengthening Partnerships, Shaping the Future Together

Following the tour, both parties held a dedicated symposium. The head of Zonci's Overseas Business Division provided a systematic introduction to the company's development history, global market presence, and future strategic plans. Representatives of the European delegation shared insights into the demand characteristics and development opportunities of the local coagulation diagnostics market. Building on this exchange, the two teams engaged in in-depth discussions on technical principles, clinical applications, and localized services. Through the integration of Chinese and European expertise, the discussions generated broad consensus on cooperation and jointly outlined a new blueprint for the international development of coagulation diagnostics.

To further validate the clinical effectiveness of the solution, the delegation also visited a tertiary hospital in Beijing to examine a real-world implementation case. Through a comprehensive and immersive on-site experience, the visitors gained in-depth insight into the actual operation of installed systems and witnessed firsthand the stable performance and outstanding capabilities of Zonci products in a real clinical environment.

This exchange was not only a business engagement, but also a testament to the friendship between the Chinese and European healthcare industries. With its open approach, professional expertise, and sincere service, Zonci earned the strong trust of its distinguished guests. The delegation highly commended Zonci’s advanced technology platform, rigorous quality management system, and comprehensive after-sales service network. Representatives expressed their recognition, stating, “Zonci’s products have reached an internationally advanced level and the company is a trustworthy partner.”

Chinese Strength, Global Reach

From serving the domestic market to supporting customers worldwide, Zonci is accelerating its internationalization strategy. Its products are now exported to more than 40 countries and regions across Europe, Southeast Asia, the Middle East, and Africa. The large-scale visit by the European delegation marks a new milestone in Zonci’s brand influence in overseas markets and lays a solid foundation for the company’s continued expansion and deeper engagement in the global market.

From technological catch-up to standing alongside and leading global peers, and from deep roots in the domestic market to an expanding global presence, an increasing number of Chinese innovators are making their mark on the world stage. Driven by innovation and trusted through quality, Zonci is accelerating its journey toward global technology expansion. Rooted in China and serving the world, Zonci remains committed to providing precise, efficient, and reliable solutions for the global coagulation diagnostics industry. Through continuous innovation and international collaboration, the company strives to contribute to the advancement of laboratory medicine worldwide and demonstrate the strength of China's medical diagnostics industry to the global community.